focus -WSS

focus

author：Wikipedia 2025-10-01 02:27:14 - browse：3

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Ebola vaccine can save some who are already sick, per new study

WSS

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

MoonLake credibility takes another hit with mid

MoonLake credibility takes another hit with mid

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

A clever new way to fix Medicaid and graduate medical education

focus

focus

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Victims of gun violence feel impacts long after bullet wound

Activists slam private health insurers over coverage restrictions

Abortion clinic in Cancun will cater to Americans

BioMarin wins approval for gene therapy to treat hemophilia A

10 million people disenrolled from Medicaid over past six months

Walensky prepares to leave CDC — and Congress — behind

Extreme heat events are a public health emergency

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Amylyx, Aurinia, and IQVIA

knowledge

Congress must protect the remaining independent doctors

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Study gives hint on South Asians’ higher risk of cardiovascular disease

Readout Newsletter: Amylyx, Aurinia, and IQVIA

FDA approves Recor Medical high blood pressure device

Readout Newsletter: Amylyx, Aurinia, and IQVIA

hotspot

Wikipedia

focus

explore